MWG Biotech AG announces expansion of their UK and Ireland sales team

11-May-2007 - As part of their on-going investment in the Oligonucleotides and Sequencing market in the UK and Ireland, MWG Biotech announced the expansion of their sales team. Avril Hamilton joins as UK and Ireland Sales Manager and her appointment is seen as key to strengthening the sales and marketing ...

Eurofins Medigenomix offers fast DNA sequencing service

Roche Diagnostics` Genome Sequencer System Powers Eurofins | Medigenomix / MWG Biotech

06-Dec-2006 - Through the purchase of the GS 20 system, Eurofins | Medigenomix / MWG Biotech becomes the first international service provider in Germany to offer their customers access to the next generation of DNA sequencing technology via their production facility in Martinsried. According to the the ...

Alnylam Grants MWG Biotech License to Fundamental RNAi Patents for Applications in the Research Products Market

26-Jul-2005 - Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has granted MWG Biotech AG a non-exclusive license to provide research products and services in RNA interference (RNAi) under the Kreutzer-Limmer patent family owned by Alnylam. This patent family covers ...

M-Medical becomes new Italian distributor of MWG Biotech

29-Mar-2005 - MWG Biotech AG announced that effective May 1, 2005, M-Medical S.r.l. will be the exclusive distributor of MWG Biotech's DNA/siRNA synthesis and DNA sequencing products in Italy. M-Medical, with headquarters in Cornaredo (Milan) Italy, is a company leader in the distribution of research products ...

MWG Biotech AG - Continuation of lab automation line secured through AVISO GmbH

08-Feb-2005 - MWG Biotech AG announces the transfer of its lab automation business to the automation specialist AVISO GmbH effective February 1. With this transaction the international continuation of the innovative robotics line is secured on a high quality level through AVISO GmbH. AVISO will also take over ...

MWG Biotech receives Frost & Sullivan 2004 Technology Innovation Award for its Microarray Technology

28-Apr-2004 - Ebersberg. MWG Biotech AG has received the renowned Frost & Sullivan 2004 Technology Innovation Award in the field of microarray technology. The Award recognises MWG Biotech's high degree of technological innovation and the strong commercial potential for its HPSF® synthesis technology in ...

MWG Biotech AG successful in important patent dispute for thermocycler apparatuses.

22-Mar-2004 - The European Patent No. 236 069 B1, titled "Apparatus and method for performing automated amplification of nucleic acid sequences and assays using heating and cooling steps" of Applera Corporation, U.S.A., was completely revoked by the European Patent Office. This patent covered the basic ...